Home -> Law Blog Directory -> Personal Injury Law Blogs -> Philadelphia Personal Injury Lawyer
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Philadelphia Personal Injury LawyerRisk for New Jersey Women Using Breast Cancer Drug And Antidepressants
By Jamie Sheller
According to a recently released study by Medco Health Solutions, women in New Jersey who use Tamoxifen in addition to certain antidepressants such as Prozac, Paxil and Zoloft, experience up to double the risk of breast cancer recurrence. These antidepressants are part of a class of drugs called selective serotonin reuptake inhibitors (SSRI). Researchers were already aware that SSRIs chemically block the activation of Tamoxifen. Close to one-third of women who use Tamoxifen also take an antidepressant. The antidepressants are used to treat depression and hot flashes in women who are taking Tamoxifen. Tamoxifen is widely used to reduce the recurrence of estrogen-dependent breast cancer. It is one of the oldest such breast cancer treatments. Women taking Tamoxifen and SSRIs should talk with their doctors "to ensure they are getting the full benefit of their Tamoxifen therapy."
Originally posted at InjuryBoard by Jamie Sheller
Full post as published by Philadelphia Personal Injury Lawyer on August 03, 2009 (boomark / email).
Mitchell Report Summary
Report on Steroid Drug Use in Major League Baseball by Senator George Mitchell
Domestic Violence
Emotional and verbal abuse qualify as domestic violence
Domestic Violence
Emotional and verbal abuse qualify as domestic violence
Domestic Violence
Steps to avoid
Antidepressants
May Increase Risk for Recurrent Cancer
Breast Cancer Patient Awarded $8.1 Million in Discrimination Case
Breast Cancer Patient Awarded $8.1 Million in Discrimination Case
$5.4 Million Quebec Breast Cancer Wait List Class Action Settlement Approved
$5.4 Million Quebec Breast Cancer Class Action Settlement Approved
Pittsburgh Cancer Center
Wanrs of Cell Phone and Cancer Risk
Canceled Insurance
Judge orders Health Net Inc. to pay $9 million settlement after terminating a policyholder's policy after being diagnosed with breast cancer.
FDA Review of Prostate Cancer Treatment Prompts Warning of Risk for Diabetes
Prostate Cancer Treatment FDA Review Prompts Warning of Risk for Diabetes

Bisphenol-A and its link to Breast Cancer
Study finds postmenopausal hormone therapy causes increased risk of lobular breast cancer
Study: Turkish women with abortions have 66% increase in breast cancer risk
Glaxo tests Tykerb versus Herceptin for early Breast Cancer Treatment
Evidence Mounts on HRT Breast Cancer Dangers
Breast Cancer Misdiagnosis Claims 80,000 Lives each Year: Report









